Inoue Tomoyuki, Uno Toshihiko, Usui Norio, Kobayakawa Shinichiro, Ichihara Kiyoshi, Ohashi Yuichi
Tane Memorial Eye Hospital, 1-1-39 Sakaigawa, Nishi-ku, Osaka, 550-0024, Japan.
Shirai Eye Hospital, Kagawa, Japan.
Jpn J Ophthalmol. 2018 Jan;62(1):24-30. doi: 10.1007/s10384-017-0545-6. Epub 2017 Nov 1.
To prospectively survey the incidence of endophthalmitis following cataract surgery and investigate the current perioperative practices in Japan.
Patients who underwent cataract surgery from January 2012 to December 2013 were included. Information on perioperative practices were recorded prospectively. Clinical characteristics were examined in cases with endophthalmitis.
A total of 63,244 patients who underwent cataract surgery in 205 facilities were enrolled. The detailed information about the current perioperative scenario surrounding cataract surgery in Japan was evaluated for the preoperative, intraoperative, and postoperative practices, i.e., patient background, prophylactic antibiotic regimen, modes of disinfection or disinfectant use, preoperative procedure, surgical method, surgical materials, surgical complication, or others. Postoperative endophthalmitis developed in 25 patients within 8 weeks postoperatively (incidence 0.04%). However, since outbreaks of toxic anterior segment syndrome (TASS) after implantation of intraocular lenses contaminated with aluminum (HOYA iSert 251 and 255) were reported, 10,261 cases implanted with the lenses had been excluded (as having a risk for non-infectious late-onset TASS). In the remaining 52,983 cases, postoperative endophthalmitis developed in 13 cases within 8 weeks postoperatively (incidence 0.025%).
This prospective survey identified the current perioperative practices representing cataract surgery and the incidence of endophthalmitis following cataract surgery (0.025%) in Japan. We believe this information can serve as a guide for future improvement in risk-reduction strategies.
前瞻性调查白内障手术后眼内炎的发生率,并研究日本目前的围手术期做法。
纳入2012年1月至2013年12月接受白内障手术的患者。前瞻性记录围手术期做法的信息。对眼内炎病例的临床特征进行检查。
共有205家机构的63244例患者接受了白内障手术。对日本目前白内障手术围手术期情况的详细信息进行了评估,包括术前、术中和术后做法,即患者背景、预防性抗生素方案、消毒方式或消毒剂使用、术前程序、手术方法、手术材料、手术并发症等。25例患者在术后8周内发生了术后眼内炎(发生率0.04%)。然而,由于报告了植入被铝污染的人工晶状体(豪雅iSert 251和255)后发生毒性眼前节综合征(TASS)的暴发,10261例植入该晶状体的病例被排除(因为有非感染性迟发性TASS的风险)。在其余52983例病例中,13例在术后8周内发生了术后眼内炎(发生率0.025%)。
这项前瞻性调查确定了日本目前代表白内障手术的围手术期做法以及白内障手术后眼内炎的发生率(0.025%)。我们相信这些信息可作为未来降低风险策略改进的指导。